The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 Diabetes
Clinical trial NCT06881472 · COMPLETED
Trial details
- NCT number
- NCT06881472
- Sponsor
- Asger Lund, MD
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-01-16
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.